Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection

Journal of Virology

Volumn 75, Issue 5, 2001, Pages 2377-2387

  Slifka, M K ^a   Pagarigan, R ^a   Mena, I ^a   Feuer, R ^a   Whitton, J L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS VACCINE; VIRUS VECTOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; CYTOTOXICITY; DNA FLANKING REGION; GENE CONSTRUCT; GENETIC CODE; IMMUNE RESPONSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MYOCARDITIS; NONHUMAN; OPEN READING FRAME; PANCREATITIS; PATHOGENICITY; PICORNAVIRUS; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL; VIROGENESIS; VIRUS ASSEMBLY; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; EPITOPES, T-LYMPHOCYTE; GLYCOPROTEINS; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINATION, GENETIC; TRANSFECTION; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0035130057     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.5.2377-2387.2001     Document Type: Article

References (57)

1. Polioviruses containing picornavirus type 1 and/or type 2 internal ribosomal entry site elements: Genetic hybrids and the expression of a foreign gene
2. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen
3. Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine
4. Engineering poliovirus as a vaccine vector for the expression of diverse antigens
5. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles
6. Antigen chimaeras of poliovirus as potential new vaccines
7. Identification of malignant cells in multiple myeloma bone marrow with immunoglobulin VH gene probes by fluorescent in situ hybridization and flow cytometry
8. Cross-presentation: A general mechanism for CTL immunity and tolerance
9. Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons
10. Myristylation of picornavirus capsid protein VP4 and its structural significance
11. Coxsackie B virus infection and onset of childhood diabetes
12. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin
13. An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies
14. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis
15. Coxsackievirus B3-induced myocarditis: Perforin exacerbates disease, but plays no detectable role in virus clearance
16. A case of protracted coxsackie virus meningoencephalitis in a marginally immunodeficient child treated successfully with intravenous immunoglobulin
17. + T-cell responses induced by DNA immunization
18. + T lymphocytes in coxsackievirus B3-induced myocarditis
19. Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization
20. Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia
21. Expression of an antigenic adenovirus epitope in a group B coxsackievirus
22. Cellular immune mechanisms in Coxsackievirus group B, type 3 induced myocarditis in Balb/C mice
23. + T-cell responses in coxsackievirus B3-induced myocarditis in mice
24. Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens
25. Complete nucleotide sequence of a strain of coxsackie B4 virus of human origin that induces diabetes in mice and its comparison with nondiabetogenic coxsackie B4 JBV strain
26. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient
27. The role of enterovirus replication in the development of acute and chronic heart muscle disease in different immunocompetent mouse strains
28. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3
29. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity
30. Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen
31. Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence
32. Lack of myristoylation of poliovirus capsid polypeptide VPO prevents the formation of virions or results in the assembly of noninfectious virus particles
33. Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein D
34. Attenuated poliovirus strain as a live vector: Expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses
35. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients
36. Coxsackievirus infection of the pancreas: Evaluation of receptor expression, pathogenesis, and immunopathology
37. The role of B lymphocytes in coxsackievirus B3 infection
38. Chronic enteroviral meningoencephalitis in agammaglobulinemia: Case report and literature review
39. Myristate-protein interactions in poliovirus: Interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions
40. Myristoylation is important at multiple stages in poliovirus assembly
41. The structure of coxsackievirus B3 at 3.5 A resolution
42. Expression of foreign proteins by poliovirus polyprotein fusion: Analysis of genetic stability reveals rapid deletions and formation of cardioviruslike open reading frames
43. Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: Roles for NK and T cell IFN-gamma production
44. Capsid protein VP4 of poliovirus is N-myristoylated
45. Severity of disease induced by a pancreatropic Coxsackie B4 virus correlates with the H-2Kq locus of the major histocompatibility complex
46. Coxsackieviruses and pancreatitis
47. Incidence of Coxsackie virus infection in patients with dilated cardiomyopathy
48. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM
49. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
50. Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease
51. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus
52. Use of CTL clones in vitro to map CTL epitopes
53. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: An immunodominant region which induces nonreciprocal CTL cross-reactivity
54. Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis
55. Lack of correlation between neutralizing antibody production and suppression of coxsackievirus B-3 replication in target organs: Evidence for involvement of mononuclear inflammatory cells in host defense
56. Viral myocarditis. A review
57. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease